CymitQuimica logo
Angiogenesi

Angiogenesi

Gli inibitori dell'angiogenesi sono composti che interferiscono con la formazione di nuovi vasi sanguigni, un processo cruciale nella crescita e metastasi del cancro. Inibendo l'angiogenesi, questi composti possono limitare l'apporto di sangue ai tumori, rallentandone o arrestando la crescita. Gli inibitori dell'angiogenesi sono fondamentali nella ricerca sul cancro e nello sviluppo terapeutico, offrendo approfondimenti sui meccanismi di progressione tumorale e potenziali trattamenti per il cancro e altre malattie legate all'angiogenesi. Presso CymitQuimica, offriamo un'ampia gamma di inibitori dell'angiogenesi di alta qualità per supportare le tue ricerche in oncologia e biologia vascolare.

Sottocategorie di "Angiogenesi"

Mostrare 6 più sottocategorie

Trovati 2121 prodotti di "Angiogenesi"

Ordinare per

Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
prodotti per pagina.
  • NMS-P953

    CAS:
    NMS-P953: JAK2 inhibitor, reduces tumor growth in SET-2 model, confirmed in vivo action, good pharmacokinetics and safety.
    Formula:C16H11ClF3N5O
    Colore e forma:Solid
    Peso molecolare:381.74
  • EGFR-IN-29

    CAS:
    EGFR-IN-29 is a potent EGFR inhibitor.
    Formula:C36H46BrN8O2P
    Colore e forma:Solid
    Peso molecolare:733.68
  • FGFR-IN-2

    CAS:
    FGFR-IN-2 (compound 1) is a potent inhibitor of FGFR, acting on FGFR1 (IC50: 7.3 nM), FGFR2 (IC50: 4.3 nM), FGFR3 (IC50: 7.6 nM) and FGFR4 (IC50: 11 nM).
    Formula:C25H30N6O2
    Colore e forma:Solid
    Peso molecolare:446.54
  • EGFR-IN-30

    CAS:
    EGFR-IN-30 is an EGFR inhibitor (IC50: 1-10 nM, <1 nM WT/mutants) with potential in cancer research.
    Formula:C28H33BrN7O2P
    Colore e forma:Solid
    Peso molecolare:610.49
  • (Rac)-PF-06250112

    CAS:
    (Rac)-PF-0625011 is a racemic mix, orally active, selective BTK inhibitor, also targeting BMX and TEC kinases.
    Formula:C22H20F2N6O2
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:438.43
  • BEBT-109

    CAS:
    BEBT-109 is a selective epidermal growth factor receptor (EGFR) inhibitor that shows anti-tumor activity in EGFR-mutant non-small cell lung cancer.
    Formula:C27H32N8O3
    Purezza:97.26%
    Colore e forma:Solid
    Peso molecolare:516.6
  • FLT3/ITD-IN-4

    CAS:
    FLT3/ITD-IN-4 inhibits FLT3-ITD mutations in acute myeloid leukemia (IC50: 2.3 nM).
    Formula:C25H22N4O5
    Colore e forma:Solid
    Peso molecolare:458.47
  • UNC4203

    CAS:
    UNC4203 inhibits MERTK (1.2 nM), AXL (140 nM), TYRO3 (42 nM), FLT3 (90 nM); potent, selective, oral.
    Formula:C30H44N6O
    Colore e forma:Solid
    Peso molecolare:504.71
  • TL02-59

    CAS:
    TL02-59: Fgr inhibitor (IC50=0.03nM), also targets Lyn (0.1nM), Hck (160nM), halts acute myelogenous leukemia growth.
    Formula:C32H34F3N5O4
    Purezza:98.77%
    Colore e forma:Solid
    Peso molecolare:609.64
  • Larixol

    CAS:
    Larixol acts as both an fMLP inhibitor and a modulator of various signaling pathways by inhibiting Src kinase, ERK1/2, p38, and AKT phosphorylation critical for
    Formula:C20H34O2
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:306.48
  • EGFR-IN-33

    CAS:
    EGFR-IN-33, a low-toxicity acrylamide, inhibits EGFR, aiding against cancer, especially NSCLC (from WO2021185348A1, comp. 13).
    Formula:C26H25ClN6O2
    Colore e forma:Solid
    Peso molecolare:488.97
  • BPR1J-340

    CAS:
    BPR1J-340, a novel potent FLT3 inhibitor, shows anticancer promise, with IC50 ~25 nM and GC50 ~5 nM, causing apoptosis in AML cells.
    Formula:C29H34N8O3
    Colore e forma:Solid
    Peso molecolare:542.63
  • Brolucizumab

    CAS:
    Brolucizumab (anti-VEGF-A scFv) potently blocks VEGF-A to reduce neovascularization in wet AMD, with picomolar binding affinity.
    Purezza:95%
    Colore e forma:Liquid
  • HER2-IN-5

    CAS:
    <p>HER2-IN-5 is an effective inhibitor of orally active HER-2.</p>
    Formula:C27H33N7O3
    Colore e forma:Solid
    Peso molecolare:503.6
  • Atiprimod dihydrochloride

    CAS:
    JAK2 inhibitor; IC50=397 nM; hampers STAT3/5 phosphorylation; curbs growth and triggers apoptosis in JAK2V617F+ cells.
    Formula:C22H46Cl2N2
    Colore e forma:Solid
    Peso molecolare:409.52
  • Upadacitinib tartrate

    CAS:
    Upadacitinib: potent, selective JAK1 inhibitor, 74x preferential to JAK2, effective in rat arthritis.
    Formula:C21H33F3N6O11
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:602.521
  • PI3K/VEGFR2-IN-1

    CAS:
    PI3K/VEGFR2-IN-1 is a potent dual inhibitor targeting both PI3K and VEGFR2 with IC50 values of 2.21 μM for PI3K and 68 μM for VEGFR2, respectively.
    Formula:C17H14ClN3OS
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:343.83
  • FLT3/ITD-IN-5

    CAS:
    FLT3/ITD-IN-5 (Example 6) is an orally active inhibitor of both FLT3 and FLT3-ITD, exhibiting IC50 values of 0.088 nM and 0.348 nM, respectively. This compound is utilized in cancer research.
    Formula:C23H25N7O2
    Colore e forma:Solid
    Peso molecolare:431.49
  • FC 11

    CAS:
    FC 11 is a reversible FAK PROTAC Degrader with DC50 of 40-370 pM and degrades pFAKtyr397 in TM3 cells within 3 hours at 100 nM.
    Formula:C41H42F3N13O9S
    Colore e forma:Solid
    Peso molecolare:949.91
  • Lifirafenib

    CAS:
    Lifirafenib (Beigene-283) is a potent inhibitor of RAF family kinases and EGFR in biochemical assays with IC50 of 23, 29 and 495 nM for the recombinant
    Formula:C25H17F3N4O3
    Purezza:97.99% - 98%
    Colore e forma:Solid
    Peso molecolare:478.42